Facts
The UK Anti-Doping Limited (“UK Anti-Doping”) charged Ali Adams (the “Athlete”) for commission relating to an Anti-Doping Rule Violation arising from the British Boxing Board of Control (“BBBofC”) Anti-Doping Rules (the “Anti-Doping Rules” or “ADR”). His sample showed the presence of 3-hydroxystanozolol, a metabolite of stanozolol, had been detected in the Sample. Stanozolol and its metabolites are Prohibited Substances and are included in the WADA 2012 Prohibited List. The Athlete was also provisionally suspended with immediate effect. On July 5, 2012, the Athlete admitted the violations.
History
By way of mitigation, the Athlete claimed that he had suffered from an ongoing neck injury for which he had received medical treatment and massage. The Athlete claimed that a massage therapist had injected him on two separate occasions with an unknown substance that he was told was an anti-inflammatory. The Athlete postulated that these injections must have been the cause of the positive test.
Decision
1. An Anti-Doping Rule Violation in accordance with ADR 2.1 and ADR 2.2 has been established in relation to stanozolol;
2. A period of Ineligibility of two years shall be the consequences imposed pursuant to ADR 10.2;
3. That period of Ineligibility is deemed to have commenced as from June 13, 2012 and will expire at midnight on 12 June 2014; and
4. The Athlete’s status during this period of Ineligibility shall be as set out in ADR 10.10.
During the period of Ineligibility, in accordance with ADR 10.10.1, the Athlete shall not be permitted to participate in any capacity in a competition or other activity (other than authorised anti-doping education or rehabilitation programs) related to his sport.
